PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Dostupné s:

Arrotex Pharmaceuticals Pty Ltd

INN (Mezinárodní Name):

pramipexole dihydrochloride monohydrate

Léková forma:

Tablet, uncoated

Složení:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

Podání:

Oral

Jednotky v balení:

10, 30, 100

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Přehled produktů:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Stav Autorizace:

Licence status A

Datum autorizace:

2014-09-23